In This Section

Division for Drug Discovery and Development (DDD)

The Division for Drug Discovery and Development (DDD) serves to help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process. The process encompasses, but is not limited to; target discovery and validation, medicinal chemistry, combinatorial chemistry, molecular modeling and drug design, structure-pharmacological function relationships, functional genomics and proteomics, high throughput screening, identification and development of natural products, nutraceuticals, pharmacokinetics and pharmacodynamics, clinical testing and drug regulation/registration, clinical contracting and pharmacoepidemiology and pharmacoeconomics.

Division Goals

  • To help its members teach, present and discuss the critical role of pharmacology in all phases of the drug discovery, development and registration process.
  • To increase communication among researchers participating in various phases of the drug discovery, development and registration process.
  • To sponsor symposia and/or colloquia on timely, related topics at annual meetings.
  • To provide special venues at these meetings for graduate students and post-doctoral fellows with related research activities and interests to present and discuss their work in a relaxed, social setting with other students, fellows and the Division for Drug Discovery and Development members.

 

Division Hashtag

Posting on social media about the DDD division? Use #ASPETDDD.

Division News

  • March 26, 2019
    The ASPET Division for Drug Discovery and Development is pleased to award Dr. Craig Lindsley from Vanderbilt University the inaugural Scientific Achievement Award in Drug Discovery and Development.
  • February 05, 2019
    We need your help to achieve our goal of making the ASPET Annual Meeting the place to discover and to present the highest quality, innovative science in pharmacology and experimental therapeutics.
  • October 15, 2018
    As the British Pharmacological Society (BPS) readies to announce, in December 2018, the next recipient of the Sir James Black Award, ASPET congratulates current recipient, Naj Sharif, PhD, for his achievements.

Job Postings